Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotricity Inc (NQ: BTCY ) 0.9500 -0.0400 (-4.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Biotricity Inc < Previous 1 2 3 4 Next > Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology July 26, 2023 Via ACCESSWIRE Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications July 25, 2023 Via ACCESSWIRE Biotricity Regains Nasdaq Listing Compliance July 21, 2023 Via ACCESSWIRE Biotricity Reports Strong Start to Fiscal Year 2024 July 06, 2023 Via ACCESSWIRE Biotricity Announces Reverse Stock Split June 30, 2023 Via ACCESSWIRE Biotricity to Host Fiscal Year 2023 Financial Results and Business Update Call on June 30th June 26, 2023 Via ACCESSWIRE Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare May 23, 2023 Via ACCESSWIRE Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth May 16, 2023 Via ACCESSWIRE Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland May 10, 2023 Via ACCESSWIRE Biotricity Reports Business Update, Financial Results for Q4 and Full Year FY23; Company Posts Robust Revenue Growth, Overall Higher Margins, with Lower SG&A Driving Clear Path to Positive Cash Flow June 30, 2023 Via ACCESSWIRE New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products April 21, 2023 Via ACCESSWIRE Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth Ahead April 19, 2023 Via ACCESSWIRE Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report April 11, 2023 Via ACCESSWIRE Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation March 07, 2023 Via ACCESSWIRE Biotricity Reports Financial Results for Fiscal 2023 Third Quarter February 14, 2023 Via ACCESSWIRE Biotricity Surpasses $10 Million in Annual Revenue Run Rate November 21, 2022 Via ACCESSWIRE Biotricity Provides Updates on its Operational and Expansion Strategy November 18, 2022 Via ACCESSWIRE Biotricity Reports Financial Results for Fiscal 2023 Second Quarter November 14, 2022 Via ACCESSWIRE Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022 November 10, 2022 Via ACCESSWIRE Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET February 09, 2023 Via ACCESSWIRE Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference February 03, 2023 Via ACCESSWIRE Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions January 26, 2023 Via ACCESSWIRE Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET January 23, 2023 Via ACCESSWIRE Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023 January 17, 2023 Via ACCESSWIRE Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib) October 04, 2022 Via ACCESSWIRE Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth December 12, 2022 Via ACCESSWIRE Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions November 16, 2022 Via ACCESSWIRE Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET November 01, 2022 Via ACCESSWIRE Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics October 26, 2022 Via ACCESSWIRE Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th October 13, 2022 Via ACCESSWIRE < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.